Breaking News Instant updates and real-time market news.

NBRV

Nabriva Therapeutics

$1.89

-0.035 (-1.82%)

04:55
10/23/19
10/23
04:55
10/23/19
04:55

Nabriva Therapeutics management to meet with Needham

Meetings to be held in Southern California on October 22 and in San Francisco, CA on October 23 hosted by Needham.

  • 23

    Oct

NBRV Nabriva Therapeutics
$1.89

-0.035 (-1.82%)

05/13/19
HCWC
05/13/19
NO CHANGE
HCWC
H.C. Wainwright affirms Buy on Nabriva ahead of expected Lefamulin approval
H.C. Wainwright analyst Ed Arce affirmed a Buy rating and $7 price target on Nabriva Therapeutics as he expects Lefamulin's FDA approval for the treatment of community-acquired bacterial pneumonia around its August 19 PDUFA date. Additionally, the analyst expects Lefamulin's EU approval in mid-2020.
08/16/19
HCWC
08/16/19
NO CHANGE
HCWC
H.C. Wainwright sees Q2 2020 approval for Nabriva's Contepo
H.C. Wainwright analyst Ed Arce affirmed a Buy rating and $7 price target on Nabriva Therapeutics after the company's announced its plan to resubmit its New Drug Application, or NDA, of Contepo. The analyst sees an approval decision in Q2 of 2020, assuming the NDA is resubmitted in early Q4 of19 as planned. Arce added that it was important that "the FDA did not request new clinical or non-clinical data, nor specify any concerns regarding Contepo's safety or efficacy in the Type A meeting minutes."
08/20/19
HCWC
08/20/19
NO CHANGE
Target $8
HCWC
Buy
Nabriva Therapeutics price target raised to $8 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce maintained a Buy rating on Nabriva Therapeutics and raised his price target to $8 from $7 after the company's Xenleta received FDA approval to treat adults with community-acquired bacteria pneumonia. With the approval, Xenleta becomes the first IV and oral antibiotic with a novel mechanism of action approved by the FDA for CABP in almost two decades, Arce tells investors in a research note. The analyst believes Xenleta's IV to bio-equivalent oral formulation could enable physicians to seamlessly transition a patient's treatment from the in-patient setting to oral dosing that may be self-administered upon discharge.
09/10/19
NORL
09/10/19
NO CHANGE
NORL
Outperform
Northland sees peak global sales of Nabriva's Xenleta at $1B
Northland analyst Carl Byrnes told investors in a research note that oral and IV formulations of Nabriva Therapeutics' XENLETA are now commercially available in the U.S. through major specialty distributors and is also under review in the EU, with anticipated approval in 12-to-15 months. Byrnes forecasts peak global sales of XENLETA at $1B, supported by XENLETA's clinical differentiation and oral/IV dosing forms. The analyst has an Outperform rating on shares of Nabriva.

TODAY'S FREE FLY STORIES

02:55
11/21/19
11/21
02:55
11/21/19
02:55
General news
FX Update: The yen edged out fresh lows before paring losses »

FX Update: The yen edged…

02:05
11/21/19
11/21
02:05
11/21/19
02:05
General news
U.S. Philly Fed manufacturing index preview: »

U.S. Philly Fed…

02:05
11/21/19
11/21
02:05
11/21/19
02:05
General news
U.S. initial jobless claims preview: »

U.S. initial jobless…

02:05
11/21/19
11/21
02:05
11/21/19
02:05
General news
U.S. Philly Fed index rose X points to X8 in November »

U.S. Philly Fed index…

02:00
11/21/19
11/21
02:00
11/21/19
02:00
General news
Asian Market Update: »

Asian Market Update: JGBs…

M

Macy's

$15.02

-0.01 (-0.07%)

, SFL

Ship Finance

$14.45

0.03 (0.21%)

20:25
11/20/19
11/20
20:25
11/20/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

M

Macy's

$15.02

-0.01 (-0.07%)

SFL

Ship Finance

$14.45

0.03 (0.21%)

BJ

BJ's Wholesale

$26.03

-0.29 (-1.10%)

PLAN

Anaplan

$49.16

0.32 (0.66%)

BERY

Berry Global

$41.90

-0.09 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

PFGC

Performance Food Group

$44.66

-0.13 (-0.29%)

20:19
11/20/19
11/20
20:19
11/20/19
20:19
Syndicate
Performance Food Group 10.12M share Secondary priced at $44.25 »

Wells Fargo and Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

ALPMY

Astellas Pharma

$0.00

(0.00%)

20:02
11/20/19
11/20
20:02
11/20/19
20:02
Hot Stocks
Astellas Pharma, Welldoc enter into Digital Therapeutics alliance »

Astellas Pharma and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

PYPL

PayPal

$104.09

-0.85 (-0.81%)

19:52
11/20/19
11/20
19:52
11/20/19
19:52
Recommendations
PayPal analyst commentary at Baird »

PayPal's Honey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 10

    Dec

SQM

SQM

$23.41

-0.35 (-1.47%)

19:42
11/20/19
11/20
19:42
11/20/19
19:42
Earnings
SQM reports Q3 EPS 23c, consensus 26c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

TNAV

TeleNav

$4.92

0.07 (1.44%)

19:37
11/20/19
11/20
19:37
11/20/19
19:37
Hot Stocks
TeleNav CEO buys 150K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

CRSP

Crispr Therapeutics

$67.31

-1.15 (-1.68%)

19:29
11/20/19
11/20
19:29
11/20/19
19:29
Syndicate
Breaking Syndicate news story on Crispr Therapeutics »

Crispr Therapeutics 4.25M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 21

    Nov

PFGC

Performance Food Group

$44.66

-0.13 (-0.29%)

19:26
11/20/19
11/20
19:26
11/20/19
19:26
Syndicate
Performance Food Group upsized 10.1M share offering said to price at $44.25 »

Report from Bloomberg. …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

INVH

Invitation Homes

$30.05

0.13 (0.43%)

19:10
11/20/19
11/20
19:10
11/20/19
19:10
Periodicals
Breaking Periodicals news story on Invitation Homes »

Invitation Homes stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

KRTX

Karuna Therapeutics

$108.42

-15.58 (-12.56%)

19:03
11/20/19
11/20
19:03
11/20/19
19:03
Syndicate
Karuna Therapeutics 2.6M share Secondary priced at $96.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

GOOG

Alphabet

$1,302.26

-12.45 (-0.95%)

, GOOGL

Alphabet Class A

$1,301.34

-11.25 (-0.86%)

18:58
11/20/19
11/20
18:58
11/20/19
18:58
Hot Stocks
Google to limit election ads audience targeting, will prohibit 'deep fakes' »

Alphabet's Google…

GOOG

Alphabet

$1,302.26

-12.45 (-0.95%)

GOOGL

Alphabet Class A

$1,301.34

-11.25 (-0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAN

Canaan

$0.00

(0.00%)

18:56
11/20/19
11/20
18:56
11/20/19
18:56
Syndicate
Canaan 10M share IPO priced at $9.00 »

The deal priced at low…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

NUAN

Nuance

$16.60

0.11 (0.67%)

, CPRT

Copart

$84.69

-1.64 (-1.90%)

18:51
11/20/19
11/20
18:51
11/20/19
18:51
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Nuance…

NUAN

Nuance

$16.60

0.11 (0.67%)

CPRT

Copart

$84.69

-1.64 (-1.90%)

LB

L Brands

$16.00

-1.19 (-6.92%)

JACK

Jack in the Box

$84.89

-0.08 (-0.09%)

SONO

Sonos

$13.87

-0.635 (-4.38%)

NTGN

Neon Therapeutics

$1.44

-0.04 (-2.70%)

TIF

Tiffany

$123.32

-0.16 (-0.13%)

UBER

Uber

$28.02

0.99 (3.66%)

LZB

La-Z-Boy

$36.23

-0.265 (-0.73%)

CUB

Cubic

$73.63

0.8 (1.10%)

NTES

NetEase

$287.68

-1.09 (-0.38%)

OPTN

Optinose

$11.42

0.84 (7.94%)

MTEM

Molecular Templates

$8.28

0.19 (2.35%)

PYPL

PayPal

$104.09

-0.85 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 04

    Dec

  • 05

    Dec

  • 05

    Dec

  • 06

    Dec

  • 10

    Dec

  • 10

    Dec

  • 21

    Nov

  • 21

    Nov

WNC

Wabash

$15.05

-0.2 (-1.31%)

18:48
11/20/19
11/20
18:48
11/20/19
18:48
Initiation
Wabash initiated at Raymond James »

Wabash initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALSN

Allison Transmission

$45.51

-0.56 (-1.22%)

18:47
11/20/19
11/20
18:47
11/20/19
18:47
Initiation
Allison Transmission initiated at Raymond James »

Allison Transmission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAV

Navistar

$30.97

-0.97 (-3.04%)

18:47
11/20/19
11/20
18:47
11/20/19
18:47
Initiation
Navistar initiated at Raymond James »

Navistar initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCAR

Paccar

$78.85

-0.59 (-0.74%)

18:47
11/20/19
11/20
18:47
11/20/19
18:47
Initiation
Paccar initiated at Raymond James »

Paccar initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMI

Cummins

$180.59

-2.36 (-1.29%)

18:46
11/20/19
11/20
18:46
11/20/19
18:46
Initiation
Cummins initiated at Raymond James »

Cummins initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

VMC

Vulcan Materials

$140.72

-0.485 (-0.34%)

18:45
11/20/19
11/20
18:45
11/20/19
18:45
Initiation
Vulcan Materials initiated at Deutsche Bank »

Vulcan Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUM

Summit Materials

$24.18

0.3 (1.26%)

18:45
11/20/19
11/20
18:45
11/20/19
18:45
Initiation
Summit Materials initiated at Deutsche Bank »

Summit Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.